x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Foundation Fighting Blindness

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

science

All Episodes

00:39:37

Eye on the Cure Podcast | Episode 97: Lindsey Rambo

Foundation Fighting Blindness ·

2025/12/19

Lindsey Rambo, a special education teaching assistant, mom, and wife, talks to host Ben Shaberman about her journey with Leber congenital amaurosis 5 (LCA5), participation in Opus Genetics' LCA5 gene therapy clinical trial, and her appearance on Good Morning America to tell her story about meaningful vision improvements.

en

00:02:12

Beacon Therapeutics Launches Clinical Trial for...

Foundation Fighting Blindness ·

2025/12/18

The company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.

en

00:43:36

Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara

Foundation Fighting Blindness ·

2025/12/05

Dr. Deniz Dalkara, a research director at INSERM in France, talks to hose Ben Shaberman about her emerging gene-agnostic, gene therapy designed to restore cone-mediated vision in people with advanced retinitis pigmentosa. Known as SPVN20 and clinically developed by SparingVision, the treatment recently moved into a clinical trial in Europe. Dr. Dakara also discusses her earlier work in retinal gene and optogenetic therapy development.

en

00:03:06

Belite Bio to Seek FDA Approval for its Stargardt...

Foundation Fighting Blindness ·

2025/12/02

Tinlarebant slowed disease progression by 36 percent in the Dragon Phase 3 clinical trial.

en

00:02:39

Opus Genetics Launches Gene Therapy Clinical Trial...

Foundation Fighting Blindness ·

2025/11/14

The Foundation funded preclinical studies for the approach and launched Opus.

en

00:20:49

Eye on the Cure Podcast | Episode 95: Greta Streimikyte

Foundation Fighting Blindness ·

2025/11/14

Greta Streimikyte, a blind para-athletic running champion from Ireland, talks to host Ben Shaberman about growing up with substantial vision loss from retinopathy of prematurity and her competitive running career. Greta has won gold in the women's 1500 meters at the 2018 and 2021 European Para Athletic Championships and is a three-time Paralympian.

en

00:53:56

Eye on the Cure Podcast | Episode 94: Dr. Victoria...

Foundation Fighting Blindness ·

2025/10/31

October 31, 2025. Dr. Victoria Claire has commissioned more than 200 sculptures, received an honorary doctorate, and is pursuing a PhD. She talks with host Ben Shaberman about her journey with retinitis pigmentosa, and how blindness has provided her with new and profound insights into herself and perceiving the world. Visitors to her current exhibition, "The Sense of Sculpture" (Oct. 18 - Nov. 1) at The Art House in Wakefield, England, are interacting with her sculptures tactilely in complete

en

00:04:23

SparingVision Launches Clinical Trial for Therapy to...

Foundation Fighting Blindness ·

2025/10/28

The approach may provide better visual acuity than current optogenetic therapies in clinical trials.

en

00:41:57

Eye on the Cure Podcast | Episode 93: Sam Seavey

Foundation Fighting Blindness ·

2025/10/17

October 17, 2025. Sam Seavey, founder and host of the acclaimed The Blind Life YouTube channel, talks with host Ben Shaberman about his journey with Stargardt disease, some of the latest assistive technologies, and how the 900+ videos on The Blind Life can be informative and helpful for people with low vision.

en

00:03:20

Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3...

Foundation Fighting Blindness ·

2025/10/02

The emerging therapy improved vision for some participants in an earlier clinical trial.

en

00:04:26

Opus Reports Vision Improvements for Three Pediatric...

Foundation Fighting Blindness ·

2025/09/30

Durable vision improvements were also observed out to 18 months for previously dosed adult patients in the trial.

en

00:30:52

Eye on the Cure Podcast | Episode 92: Lance Baldo, MD

Foundation Fighting Blindness ·

2025/09/26

Lance Baldo, MD, CEO at Beacon Therapeutics, talks to host Ben Shaberman about his company's fully enrolled Phase 3 VISTA clinical trial for laru-zova, a gene therapy for X-linked retinitis pigmentosa (RPGR mutations) that's showed promising results in earlier trials. They also discuss Beacon's forthcoming clinical trial for its dry age-related macular degeneration gene therapy.

en

00:02:57

Agnes Gund – Renowned Philanthropist, Social Justice...

Foundation Fighting Blindness ·

2025/09/22

The documentary “Aggie: An Incredible Story of Art and Justice” chronicles her story.

en

00:03:37

Nacuity’s Antioxidative Therapy NACA Performs...

Foundation Fighting Blindness ·

2025/09/12

NACA is a gene-agnostic, oral medication designed to preserve vision in people with retinitis pigmentosa and Usher syndrome.

en

00:22:19

Eye on the Cure Podcast | Episode 91: Dr. George Magrath

Foundation Fighting Blindness ·

2025/09/05

September 5, 2025. Dr. George Magrath, CEO of Opus Genetics, talks with host Ben Shaberman about the company's evolution and progress in clinically developing gene therapies for several inherited retinal diseases including those caused by mutations in the genes: LCA5, BEST1, RHO, RDH12, MERTK, NMNAT1, and CNGB1.

en

00:02:07

Opus Genetics Receives FDA Clearance to Launch...

Foundation Fighting Blindness ·

2025/08/22

The Foundation funded earlier, proof-of-concept studies for the Best1 gene therapy and later launched Opus to develop several IRD gene therapies.

en

00:03:07

jCyte Launches New Phase 2 Clinical Trial for its...

Foundation Fighting Blindness ·

2025/08/20

The trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.

en

00:27:11

Eye on the Cure Podcast | Episode 90: Dr. Christina...

Foundation Fighting Blindness ·

2025/08/08

August 8, 2025. Dr. Christina Ohnsman talks to host Ben Shaberman about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions. Dr. Ohnsman reviews early results for a Batten disease (CLN2) retinal gene therapy clinical trial. She also reflects on her previous work as a pediatric ophthalmologist and roles with Spark Therapeutics and Regenxbio.

en

00:03:05

Wet AMD Treatment Susvimo Preserves Vision for Five...

Foundation Fighting Blindness ·

2025/08/06

Susvimo is an FDA-approved treatment that continuously delivers drug through a tiny, implanted capsule

en

00:37:22

Eye on the Cure Podcast | Episode 89: Dr. Christine...

Foundation Fighting Blindness ·

2025/07/25

July 25, 2025. Dr. Christine Curcio, one of the world's foremost experts in age-related macular degeneration (AMD) pathogenesis and the associated risk of advanced vision loss, talks to host Ben Shaberman about her epical career and recent Proctor Medal lecture with Dr. Cynthia Owsley at the 2025 meeting of the Association for Eye and Vision Research (ARVO). Her work has led to a highly effective test for predicting who is at greatest risk of losing vision from AMD.

en

242 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter